All regulations
Rulemaking
IRS
RIN 1545-BR16
Open for Comments
IRS-2026-0002
Statutory Updates to Branded Prescription Drug Fee Regulations (REG-103430-24)
CC:ECE
Documents
2
Comments
2
Description
This document proposes amendments to regulations regarding the annual fee imposed on covered entities engaged in the business of manufacturing or importing certain branded prescription drugs.
Key Dates
Comment Period OpensJan 2, 2026
Comment Period ClosesMar 4, 2026
Documents
| Type | Title | Status |
|---|---|---|
Proposed Rule |
Comment Statistics
Total Comments
2
Keywords
password
Data from Regulations.gov